110 related articles for article (PubMed ID: 9618940)
1. Sulfite induces release of lipid mediators by alveolar macrophages.
Beck-Speier I; Dayal N; Denzlinger C; Haberl C; Maier KL
Z Naturforsch C J Biosci; 1998; 53(3-4):264-72. PubMed ID: 9618940
[TBL] [Abstract][Full Text] [Related]
2. Sulfur-related air pollutants induce the generation of platelet-activating factor, 5-lipoxygenase- and cyclooxygenase-products in canine alveolar macrophages via activation of phospholipases A2.
Beck-Speier I; Dayal N; Denzlinger C; Haberl C; Maier KL; Ziesenis A; Heyder J
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):217-34. PubMed ID: 14518563
[TBL] [Abstract][Full Text] [Related]
3. Pro-inflammatory response of alveolar macrophages induced by sulphite: studies with lucigenin-dependent chemiluminescence.
Beck-Speier I; Dayal N; Maier KL
J Biolumin Chemilumin; 1998; 13(2):91-9. PubMed ID: 9633012
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 limits arachidonic acid availability and inhibits leukotriene B4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism.
Christman BW; Christman JW; Dworski R; Blair IA; Prakash C
J Immunol; 1993 Aug; 151(4):2096-104. PubMed ID: 8393898
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor increases leukotriene B4 release in stimulated alveolar macrophages from asthmatic patients.
Shindo K; Koide K; Fukumura M
Eur Respir J; 1998 May; 11(5):1098-104. PubMed ID: 9648962
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
Dubois C; Bissonnette E; Rola-Pleszczynski M
J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
[TBL] [Abstract][Full Text] [Related]
7. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
McDonald PP; McColl SR; Braquet P; Borgeat P
Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor enhances interleukin-6 production by alveolar macrophages.
Thivierge M; Rola-Pleszczynski M
J Allergy Clin Immunol; 1992 Nov; 90(5):796-802. PubMed ID: 1331218
[TBL] [Abstract][Full Text] [Related]
9. Regulation of alveolar macrophage production of chemoattractants by leukotriene B4 and prostaglandin E2.
Christman JW; Christman BW; Shepherd VL; Rinaldo JE
Am J Respir Cell Mol Biol; 1991 Sep; 5(3):297-304. PubMed ID: 1654953
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity.
Sato E; Koyama S; Nomura H; Kubo K; Sekiguchi M
J Immunol; 1996 Oct; 157(7):3122-9. PubMed ID: 8816423
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
Bozza PT; Payne JL; Goulet JL; Weller PF
J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis.
Thomsen MK; Larsen CG; Thomsen HK; Kirstein D; Skak-Nielsen T; Ahnfelt-Rønne I; Thestrup-Pedersen K
J Invest Dermatol; 1991 Feb; 96(2):260-6. PubMed ID: 1846901
[TBL] [Abstract][Full Text] [Related]
14. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
Hidi R; Coëffier E; Vargaftig BB
J Leukoc Biol; 1992 May; 51(5):425-31. PubMed ID: 1318347
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
[TBL] [Abstract][Full Text] [Related]
16. Platelet activating factor amplifies human neutrophil adherence to bovine endothelial cells: evidence for a lipoxygenase dependent mechanism.
Damtew B; Spagnuolo PJ
Inflammation; 1992 Oct; 16(5):425-36. PubMed ID: 1330924
[TBL] [Abstract][Full Text] [Related]
17. Cyclic-AMP level and eicosanoid release from alveolar macrophages are differentially affected by high and low dose of platelet activating factor.
Beusenberg FD; Bonta IL; van Amsterdam JG
Biochem Pharmacol; 1994 Feb; 47(3):588-90. PubMed ID: 8117329
[TBL] [Abstract][Full Text] [Related]
18. Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):825-31. PubMed ID: 8387780
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
Rossi AG; MacIntyre DE; Jones CJ; McMillan RM
J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
[TBL] [Abstract][Full Text] [Related]
20. Comparison of neutrophil chemotactic factor release by human and rabbit alveolar macrophages in response to tannin exposure.
Specks U; Kreofsky TJ; Limper AH; Bates PJ; Brutinel WM; Rohrbach MS
J Lab Clin Med; 1995 Feb; 125(2):237-46. PubMed ID: 7844471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
